Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance

Cancer

Volumn 117, Issue 9, 2011, Pages 1864-1873

  Park, Haeng Ran ^a   Kim, Se Heon ^a   Lee, Sei Young ^b   Sung, Ji Min ^a   Park, Ae Ran ^a   Kang, Suki ^a   Kim, Baek Gil ^a   Choi, Yoon Pyo ^a   Kim, Yong Bae ^a   Cho, Nam Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

head and neck squamous cell carcinoma; Nm23 H1; nuclear localization; predictor; radiation resistance

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE A;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DOWN REGULATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEOMICS; RADIATION DOSE; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; HEAD AND NECK NEOPLASMS; HUMANS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PREDICTIVE VALUE OF TESTS; RADIATION TOLERANCE; TUMOR MARKERS, BIOLOGICAL;

EID: 79955447372     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25760     Document Type: Article

References (34)

1. Hardisson D., Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2003; 260: 502-508. (Pubitemid 37363578)
2. Le Tourneau C, Siu LL., Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck. Curr Opin Oncol. 2008; 20: 256-263. (Pubitemid 351507544)
3. Dassonville O, Formento JL, Francoual M, et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol. 1993; 11: 1873-1878. (Pubitemid 23304610)
4. Wen QH, Miwa T, Yoshizaki T, Nagayama I, Furukawa M, Nishijima H., Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. Laryngoscope. 1996; 106: 884-888. (Pubitemid 26242129)
5. Thariat J, Yildirim G, Mason KA, Garden AS, Milas L, Ang KK., Combination of radiotherapy with EGFR antagonists for head and neck carcinoma. Int J Clin Oncol. 2007; 12: 99-110. (Pubitemid 46632467)
6. Gallo O, Chiarelli I, Boddi V, Bocciolini C, Bruschini L, Porfirio B., Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy. Int J Cancer. 1999; 84: 573-579.
7. Gupta AK, McKenna WG, Weber CN, et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res. 2002; 8: 885-892. (Pubitemid 34742122)
8. Koukourakis MI, Giatromanolaki A, Danielidis V, Sivridis E., Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy. Int J Radiat Biol. 2008; 84: 47-52. (Pubitemid 350208780)
9. Kim MK, Cho KJ, Kwon GY, et al. ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer. Eur J Cancer. 2008; 44: 54-60. (Pubitemid 350256935)
10. Sims-Mourtada J, Izzo JG, Apisarnthanarax S, et al. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res. 2006; 12: 6565-6572. (Pubitemid 44799732)
11. Lascu L., The nucleoside diphosphate kinases 1973-2000. J Bioenerg Biomembr. 2000; 32: 213-214.
12. Kantor JD, McCormick B, Steeg PS, Zetter BR., Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res. 1993; 53: 1971-1973. (Pubitemid 23145710)
13. Hartsough MT, Morrison DK, Salerno M, et al. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem. 2002; 277: 32389-32399. (Pubitemid 34969057)
14. Salerno M, Palmieri D, Bouadis A, Halverson D, Steeg PS., Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells. Mol Cell Biol. 2005; 25: 1379-1388. (Pubitemid 40204915)
15. Eckes B, Dogic D, Colucci-Guyon E, et al. Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci. 1998; 111: 1897-1907. (Pubitemid 28370534)
16. Otero AS., Copurification of vimentin, energy metabolism enzymes, and a MER5 homolog with nucleoside diphosphate kinase. Identification of tissue-specific interactions. J Biol Chem. 1997; 272: 14690-14694.
17. Ki DH, Jeung HC, Park CH, et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer. 2007; 121: 2005-2012.
18. Kim DS, Choi YP, Kang S, et al. Panel of candidate biomarkers for renal cell carcinoma. J Proteome Res. 2010; 9: 3710-3719.
19. Frederick BA, Helfrich BA, Coldren CD, et al. Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and nonsmall cell lung carcinoma. Mol Cancer Ther. 2007; 6: 1683-1691. (Pubitemid 46954044)
20. Ishigami T, Uzawa K, Higo M, et al. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer. 2007; 120: 2262-2270. (Pubitemid 46555867)
21. Amundson SA, Bittner M, Chen Y, Trent J, Meltzer P, Fornace AJ Jr,. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene. 1999; 18: 3666-3672. (Pubitemid 29322393)
22. Lee YS, Chang HW, Jeong JE, Lee SW, Kim SY., Proteomic analysis of 2 head and neck cancer cell lines presenting different radiation sensitivity. Acta Otolaryngol. 2008; 128: 86-92.
23. Kaetzel DM, Zhang Q, Yang M, McCorkle JR, Ma D, Craven RJ., Potential roles of 3â-5â exonuclease activity of NM23-H1 in DNA repair and malignant progression. J Bioenerg Biomembr. 2006; 38: 163-167. (Pubitemid 44946223)
24. Yang M, Jarrett SG, Craven R, Kaetzel DM., YNK1, the yeast homolog of human metastasis suppressor NM23, is required for repair of UV radiation- and etoposide-induced DNA damage. Mutat Res. 2009; 660: 74-78.
25. Ismail NI, Kaur G, Hashim H, Hassan MS., Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression. Cancer Cell Int. 2008; 8: 6.
26. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J., Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell. 2003; 112: 659-672. (Pubitemid 36331778)
27. Guan Z, Wang XR, Zhu XF, et al. Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res. 2007; 67: 10436-10444. (Pubitemid 350070819)
28. Du J, Hannon GJ., The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. Nucleic Acids Res. 2002; 30: 5465-5475. (Pubitemid 36113924)
29. An HJ, Kim DS, Park YK, et al. Comparative proteomics of ovarian epithelial tumors. J Proteome Res. 2006; 5: 1082-1090. (Pubitemid 43727786)
30. Niitsu N, Nakamine H, Okamoto M, et al. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma. Br J Haematol. 2003; 123: 621-630. (Pubitemid 37468058)
31. Takeda O, Handa M, Uehara T, et al. An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas. Br J Cancer. 1996; 74: 1620-1626. (Pubitemid 26386091)
32. Zou M, Shi Y, al-Sedairy S, Farid NR., High levels of Nm23 gene expression in advanced stage of thyroid carcinomas. Br J Cancer. 1993; 68: 385-388. (Pubitemid 23229442)
33. Gunduz M, Ayhan A, Gullu I, et al. nm23 Protein expression in larynx cancer and the relationship with metastasis. Eur J Cancer. 1997; 33: 2338-2341. (Pubitemid 28129173)
34. Wang YF, Chow KC, Chang SY, et al. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. Br J Cancer. 2004; 90: 2186-2193.